Extendicare (TSE:EXE – Get Free Report) had its price objective hoisted by analysts at Canaccord Genuity Group from C$37.00 to C$44.00 in a research note issued on Monday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 36.69% from the company’s previous close.
Several other analysts have also recently commented on EXE. National Bank Financial boosted their price target on shares of Extendicare from C$34.00 to C$40.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 27th. Desjardins reduced their target price on Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a report on Monday. TD boosted their target price on Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Finally, BMO Capital Markets increased their price target on Extendicare from C$30.00 to C$38.00 in a research note on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$35.44.
View Our Latest Research Report on EXE
Extendicare Price Performance
Extendicare (TSE:EXE – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported C$0.32 EPS for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The firm had revenue of C$611.04 million for the quarter. On average, equities analysts forecast that Extendicare will post 0.6134729 EPS for the current year.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
